Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Buy
64
ORGO Quote, Financials, Valuation and Earnings
Last price:
$5.22
Seasonality move
:
9.05%
Day range:
$5.06 - $5.40
52-week range:
$2.21 - $6.71
Dividend yield:
0%
P/E ratio:
70.39x
P/S ratio:
1.46x
P/B ratio:
2.57x
Volume:
1.3M
Avg. volume:
1.5M
1-year change:
113.65%
Market cap:
$674.7M
Revenue:
$482M
EPS (TTM):
-$0.02
Earnings Data
Next earnings date for ORGO
May 08
2025
Most recent earnings per share
$0.04
Beat by $0.02
(Feb 27/2025)
Consensus Estimate
$0.02
(Feb 27/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ORGO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $102.2M | -- | -- | $0.03 | -- |
| 05/08/2025 | Q1 | $90.8M | -- | -- | -$0.03 | -- |
| 02/27/2025 | Q4 | $109.6M | $126.7M | $0.04 | $0.02 | $0.02 |
| 11/12/2024 | Q3 | $109.5M | $115.2M | $0.09 | $0.02 | $0.07 |
| 08/08/2024 | Q2 | $121.3M | $130.2M | -$0.13 | $0.02 | -$0.15 |
| 05/09/2024 | Q1 | $101.1M | $110M | -$0.02 | -$0.03 | $0.01 |
| 02/29/2024 | Q4 | $109.1M | $99.7M | -$0.00 | $0.02 | -$0.02 |
| 11/09/2023 | Q3 | -- | -- | $0.02 | $0.01 | $0.01 |
| 08/09/2023 | Q2 | -- | -- | $0.04 | $0.04 | -- |
| 05/10/2023 | Q1 | -- | -- | -$0.02 | -- | -- |
| 03/01/2023 | Q4 | -- | -- | $0.06 | $0.05 | $0.01 |
| 11/09/2022 | Q3 | -- | -- | $0.00 | $0.07 | -$0.06 |
| 08/09/2022 | Q2 | -- | -- | $0.07 | $0.08 | -$0.01 |
| 05/10/2022 | Q1 | -- | -- | $0.00 | $0.06 | -$0.06 |
| 03/01/2022 | Q4 | -- | -- | $0.39 | $0.10 | $0.30 |
| 11/09/2021 | Q3 | -- | -- | $0.09 | $0.06 | $0.03 |
| 08/09/2021 | Q2 | -- | -- | $0.15 | $0.06 | $0.09 |
| 05/10/2021 | Q1 | -- | -- | $0.07 | -$0.02 | $0.09 |
| 03/16/2021 | Q4 | -- | -- | $0.15 | $0.12 | $0.03 |
| 11/09/2020 | Q3 | -- | -- | $0.19 | -$0.07 | $0.26 |
| 08/10/2020 | Q2 | -- | -- | -$0.05 | -$0.26 | $0.21 |
| 05/11/2020 | Q1 | -- | -- | -$0.16 | -$0.13 | -$0.03 |
| 03/09/2020 | Q4 | -- | -- | -$0.04 | -$0.09 | $0.05 |
| 11/12/2019 | Q3 | -- | -- | -$0.12 | -$0.13 | $0.01 |
| 08/09/2019 | Q2 | -- | -- | -$0.11 | -$0.13 | $0.02 |
| 05/10/2019 | Q1 | -- | -- | -$0.15 | -$0.11 | -$0.05 |
Organogenesis Holdings Earnings Questions
-
How Much did Organogenesis Holdings Generate in Revenue Last Quarter?
Organogenesis Holdings reported $126.7M worth of top line sales in its most recent quarter.
-
Did Organogenesis Holdings Beat Earnings Last Quarter?
Organogenesis Holdings announced earnings per share of $0.04 which represents a beat of analyst forecast a $0.02 per share.
-
Is Organogenesis Holdings Profitable?
Organogenesis Holdings reported $95.6M that represents $0.74 per share over the last quarter.
-
What is the Analyst Consensus for Organogenesis Holdings EPS Next Year?
Organogenesis Holdings's earnings are forecast to grow from -$0.01 per share to $0.11 per share next year representing an increase of 175%.
-
When is Organogenesis Holdings's Earnings Date?
Organogenesis Holdings's next earnings date is May 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Is RTX The Best Growth Stock?
Among the worldwide aerospace and defense markets, the US controls…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is up 0.02% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11.22% over the past day.
